Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

10-Year hip implant study ends early – what we know

NCT ID NCT04193163

Knowledge-focused Sponsor: FH ORTHO Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study followed 10 people who received an ESOP 2 hip stem during total hip replacement. Researchers wanted to see how safe and effective the device was over 10 years in real-life use. The study was stopped early, so the full long-term picture is incomplete.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ESOP 2 cementless femoral stem (hip prosthesis device)
What this could lead to
If successful, this study could confirm that the ESOP 2 stem is safe and works well over many years for hip replacement patients.
What could go wrong
This was a very small study (10 people) that ended early, so results may not apply to all patients. Long-term data is limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

10 people

The number who actually took part.

Started

Dec 2019

Finished

Sep 2022

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients from participating hospitals will be enrolled as part of their clinical routine care.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subject implanted with ESOP 2 stem in one of the following indication according to the instructions for use: hip disorders; femoral neck fracture * Subject who received an information form and is willing to participate in the study Exclusion Criteria: * Contraindications described in the instructions for use * Usual surgical contraindications * Subject who is not able to express his/her non-opposition

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Femoral neck fracture are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

femoral neck fracture hip fracture

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hip disease Hip fractures

Contacts and locations

Locations

  • CH Pasteur

    Colmar, 68024, France

  • CH Raymond POINCARE

    Garches, 92380, France

  • CH de Haguenau

    Haguenau, 67504, France

  • Clinique Tivoli Ducos

    Bordeaux, 33000, France

  • Clinique du Val d'Ouest

    Écully, 69130, France

  • Groupe Hospitalier Pitié-Salpêtrière

    Paris, 75651, France

  • Nouvelle Clinique Bel-Air

    Bordeaux, 33000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.